Sentinel Lymph Node Biopsy in Vulvar Cancer. Literature Review
https://doi.org/10.24060/2076-3093-2024-14-1-42-51
Abstract
Vulvar cancer is a fairly rare pathology. One of the factors in its aggressive course is the high metastatic potential of such tumors. The presence of metastases in inguinal lymph nodes constitutes a major prognostic factor. Starting from a 1-mm depth of invasion (FIGO IB), the risk of metastatic lymph node involvement increases to 35%, which makes lymph node examination important. Until 1990, inguinofemoral lymphadenectomy was performed, among other things, to assess the status of inguinal lymph nodes in vulvar cancer. Inguinofemoral lymphadenectomy constitutes a rather extensive operation that is accompanied by a large number of postoperative complications, both in the short- and long-term periods. A study on the role of sentinel lymph node biopsy was published in 2008. Van der Zee et al. provided important evidence that the sentinel lymph node concept can be safely applied in vulvar cancer patients. In the surgical treatment of vulvar cancer, it is essential to assess the sentinel lymph node status in order to reduce the extent of surgical intervention.
About the Author
К. V. Menshikov
Bashkir State Medical University; Republican Clinical Oncology Dispensary
Russian Federation
Russian Federation
Konstantin V. Menshikov — Cand. Sci. (Med.), Assoc. Prof., Department of Oncology and Clinical Morphology, Chemotherapy Unit
Ufa
References
1. Uzan C., Canlorbe G., Miangon P., Conforti R. Référentiel cancer de la vulve. Paris; 2018.
2. Siegel R.L., Miller K.D., Wagle N.S., Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17–48. DOI: 10.3322/caac.21763
3. Network NCC. NCCN Clinical Practice Guidelines in oncology for vulvar cancer. NCCN; 2024.
4. Burger M.P., Hollema H., Emanuels A.G., Krans M., Pras E., Bouma J. The importance of the groin node status for the survival of T1 and T2 vulval carcinoma patients. Gynecol Oncol. 1995;57(3):327–34. DOI: 10.1006/gyno.1995.1151
5. Siegel R.L., Miller K.D., Fuchs H.E., Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72:7–33. DOI: 10.3322/caac.21708
6. Sedlis A., Homesley H., Bundy B.N., Marshall R., Yordan E., Hacker N., et al. Positive groin lymph nodes in superficial squamous cell vulvar cancer. A Gynecologic Oncology Group Study. Am J Obstet Gynecol. 1987;156(5):1159–64. DOI: 10.1016/0002-9378(87)90132-3
7. Lipatov H.E., Menshikov K.V., Tursumetov D.S., Pushkarev A.V., Menshikov I.A., Lipatov D.O., et al. Comparative assessment of the quality of life in patients after surgical treatment of vulvar cancer. Palliative Medicine and Rehabilitation. 2020;1:20–4 (In Russ.).
8. Mahner S., Jueckstock J., Hilpert F., Neuser P., Harter P., de Gregorio N., et al. Adjuvant therapy in lymph node-positive vulvar cancer: the AGO-CaRE-1 study. J Natl Cancer Inst. 2015;107(3):dju426. DOI: 10.1093/jnci/dju426
9. Brincat M.R., Muscat Baron Y. Sentinel lymph node biopsy in the management of vulvar carcinoma: an evidence-based insight. Int J Gynecol Cancer. 2017;27(8):1769–73. DOI: 10.1097/IGC.0000000000001075
10. Levenback C.F. How safe is sentinel lymph node biopsy in patients with vulvar cancer? J Clin Oncol. 2008;26(6):828–9. DOI: 10.1200/JCO.2007.14.7124
11. Schnürch H.G., Ackermann S., Alt C.D., Barinoff J., Böing C., Dannecker C., et al. Diagnosis, therapy and follow-up care of vulvar cancer and its precursors. Guideline of the DGGG and DKG (S2k-Level, AWMF Registry Number 015/059, November 2015. Geburtshilfe Frauenheilkd. 2016;76(10):1035–49. DOI: 10.1055/s-0042-103728
12. Hampl M., Hantschmann P., Michels W., Hillemanns P.; German Multicenter Study Group. Validation of the accuracy of the sentinel lymph node procedure in patients with vulvar cancer: results of a multicenter study in Germany. Gynecol Oncol. 2008;111(2):282–8. DOI: 10.1016/j.ygyno.2008.08.007
13. Te Grootenhuis N.C., van der Zee A.G., van Doorn H.C., van der Velden J., Vergote I., Zanagnolo V., et al. Sentinel nodes in vulvar cancer: Long-term follow-up of the GROningen INternational Study on Sentinel nodes in Vulvar cancer (GROINSS-V) I. Gynecol Oncol. 2016;140(1):8–14. DOI: 10.1016/j.ygyno.2015.09.077
14. Van der Zee A.G., Oonk M.H., De Hullu J.A., Ansink A.C., Vergote I., Verheijen R.H., et al. Sentinel node dissection is safe in the treatment of early-stage vulvar cancer. J Clin Oncol. 2008;26(6):884–9. DOI: 10.1200/JCO.2007.14.0566
15. Ramirez P.T., Levenback C. Long-term outcomes of sentinel node mapping in vulvar cancer: A time to cheer with enthusiasm or pause and question current practice? Gynecol Oncol. 2016;140(1):1–2. DOI: 10.1016/j.ygyno.2015.12.013
16. Cabanas R.M. An approach for the treatment of penile carcinoma. Cancer. 1977;39(2):456–66. DOI: 10.1002/1097-0142(197702)39:2<456::aid-cncr2820390214>3.0.co;2-i
17. Razumova Z., Bizzarri N., Pletnev A., Theofanakis C., Selcuk I., van der Steen-Banasik E., et al. 22nd meeting of the European Society of Gynaecological Oncology (ESGO 2021) report. Int J Gynecol Cancer. 2022;32(11):1363–9. DOI: 10.1136/ijgc-2022-003593
18. Stehman F.B., Bundy B.N., Dvoretsky P.M., Creasman W.T. Early stage I carcinoma of the vulva treated with ipsilateral superficial inguinal lymphadenectomy and modified radical hemivulvectomy: a prospective study of the Gynecologic Oncology Group. Obstet Gynecol. 1992;79(4):490–7. PMID: 1553164
19. Morton D.L., Wen D.R., Wong J.H., Economou J.S., Cagle L.A., Storm F.K., et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 1992;127(4):392–9. DOI: 10.1001/archsurg.1992.01420040034005
20. Balch C.M., Buzaid A.C., Soong S.J., Atkins M.B., Cascinelli N., Coit D.G., et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol. 2001;19(16):3635–48. DOI: 10.1200/JCO.2001.19.16.3635
21. de Hullu J.A., Ansink A.C., Tymstra T., van der Zee A.G. What doctors and patients think about false-negative sentinel lymph nodes in vulvar cancer. J Psychosom Obstet Gynaecol. 2001;22(4):199–203. DOI: 10.3109/01674820109049974
22. Collarino A., Fuoco V., Garganese G., Pereira Arias-Bouda L.M., Perotti G., Manca G., et al. Lymphoscintigraphy and sentinel lymph node biopsy in vulvar carcinoma: update from a European expert panel. Eur J Nucl Med Mol Imaging. 2020;47(5):1261–74. DOI: 10.1007/s00259-019-04650-8
23. Preti M., Borella F., Gallio N., Bertero L., Heller D.S., Vieira-Baptista P., et al. Superficially invasive vulvar squamous cell carcinoma: a 37-year-long experience of a tertiary referral center. Cancers (Basel). 2021;13(15):3859. DOI: 10.3390/cancers13153859
24. Tsopelas C. Particle size analysis of (99m)Tc-labeled and unlabeled antimony trisulfide and rhenium sulfide colloids intended for lymphoscintigraphic application. J Nucl Med. 2001;42(3):460–6. PMID: 11337524
25. Núñez E.G., Faintuch B.L., Teodoro R., Wiecek D.P., Martinelli J.R., da Silva N.G., et al. Influence of colloid particle profile on sentinel lymph node uptake. Nucl Med Biol. 2009;36(7):741–7. DOI: 10.1016/j.nucmedbio.2009.04.009
26. Jimenez I.R., Roca M., Vega E., García M.L., Benitez A., Bajén M., et al. Particle sizes of colloids to be used in sentinel lymph node radiolocalization. Nucl Med Commun. 2008;29(2):166–72. DOI: 10.1097/MNM.0b013e3282f258d9
27. Mirzaei S., Rodrigues M., Hoffmann B., Knoll P., Riegler-Keil M., Kreuzer W., et al. Sentinel lymph node detection with large human serum albumin colloid particles in breast cancer. Eur J Nucl Med Mol Imaging. 2003;30(6):874–8. DOI: 10.1007/s00259-003-1147-8
28. Meads C., Sutton A.J., Rosenthal A.N., Małysiak S., Kowalska M., Zapalska A., et al. Sentinel lymph node biopsy in vulval cancer: systematic review and meta-analysis. Br J Cancer. 2014;110(12):2837–46. DOI: 10.1038/bjc.2014.205
29. Wilke L.G., McCall L.M., Posther K.E., Whitworth P.W., Reintgen D.S., Leitch A.M., et al. Surgical complications associated with sentinel lymph node biopsy: results from a prospective international cooperative group trial. Ann Surg Oncol. 2006;13(4):491–500. DOI: 10.1245/ASO.2006.05.013
30. Hassanzade M., Attaran M., Treglia G., Yousefi Z., Sadeghi R. Lymphatic mapping and sentinel node biopsy in squamous cell carcinoma of the vulva: systematic review and meta-analysis of the literature. Gynecol Oncol. 2013;130(1):237–45. DOI: 10.1016/j.ygyno.2013.04.023
31. Collège National des Gynécologues et Obstétriciens Français: Réunion du 28 janvier 2005 à lille. J. Gynecol. Obstet. Biol. Reprod. 2005;34(513). DOI: 10.1016/S0368-2315(05)82867-4
32. Giannini A., D’Oria O., Chiofalo B., Bruno V., Baiocco E., Mancini E., et al. The giant steps in surgical downsizing toward a personalized treatment of vulvar cancer. J Obstet Gynaecol Res. 2022;48(3):533–40. DOI: 10.1111/jog.15103
33. Zapardiel I., Alvarez J., Barahona M., Barri P., Boldo A., Bresco P., et al. Utility of intraoperative fluorescence imaging in gynecologic surgery: systematic review and consensus statement. Ann Surg Oncol. 2021;28(6):3266–78. DOI: 10.1245/s10434-020-09222-x
34. Vermersch C., Raia Barjat T., Perrot M., Lima S., Chauleur C. Place of indocyanine green coupled with fluorescence imaging in research of breast cancer sentinel node. Bull Cancer. 2016;103(4):381–8. DOI: 10.1016/j.bulcan.2016.01.015
35. Papadia A., Mueller M.D. ICG-Enhanced Fluorescence-Guided SLN Mapping in Gynecological Malignancies. Tuttlingen: Endo Press; 2018.
36. Raffone A., Raimondo D., Raspollini A., Oliviero A., Travaglino A., Renzulli F., et al. Comparison between laparoscopic and robotic approach for sentinel lymph node biopsy in endometrial carcinoma women. J Pers Med. 2022;13(1):29. DOI: 10.3390/jpm13010029
37. Verbeek F.P., Tummers Q.R., Rietbergen D.D., Peters A.A., Schaafsma B.E., van de Velde C.J., et al. Sentinel lymph node biopsy in vulvar cancer using combined radioactive and fluorescence guidance. Int J Gynecol Cancer. 2015;25(6):1086–93. DOI: 10.1097/IGC.0000000000000419
38. Hutteman M., van der Vorst J.R., Gaarenstroom K.N., Peters A.A., Mieog J.S., Schaafsma B.E., et al. Optimization of near-infrared fluorescent sentinel lymph node mapping for vulvar cancer. Am J Obstet Gynecol. 2012;206(1):89.e1–5. DOI: 10.1016/j.ajog.2011.07.039
39. Wang T., Xu Y., Shao W., Wang C. Sentinel lymph node mapping: current applications and future perspectives in gynecology malignant tumors. Front Med (Lausanne). 2022;9:922585. DOI: 10.3389/fmed.2022.922585
40. Schaafsma B.E., Verbeek F.P., Peters A.A., van der Vorst J.R., de Kroon C.D., van Poelgeest M.I., et al. Near-infrared fluorescence sentinel lymph node biopsy in vulvar cancer: a randomised comparison of lymphatic tracers. BJOG. 2013;120(6):758–64. DOI: 10.1111/1471-0528.12173
41. Mathéron H.M., van den Berg N.S., Brouwer O.R., Kleinjan G.H., van Driel W.J., Trum J.W., et al. Multimodal surgical guidance towards the sentinel node in vulvar cancer. Gynecol Oncol. 2013;131(3):720–5. DOI: 10.1016/j.ygyno.2013.09.007
42. Prader S., du Bois A., Harter P., Breit E., Schneider S., Baert T., et al. Sentinel lymph node mapping with fluorescent and radioactive tracers in vulvar cancer patients. Arch Gynecol Obstet. 2020;301(3):729–36. DOI: 10.1007/s00404-019-05415-2
43. Broach V., Abu-Rustum N.R., Sonoda Y., Brown C.L., Jewell E., Gardner G., et al. Evolution and outcomes of sentinel lymph node mapping in vulvar cancer. Int J Gynecol Cancer. 2020;30(3):383–6. DOI: 10.1136/ijgc-2019-000936
44. Deken M.M., van Doorn H.C., Verver D., Boogerd L.S.F., de Valk K.S., Rietbergen D.D.D., et al. Near-infrared fluorescence imaging compared to standard sentinel lymph node detection with blue dye in patients with vulvar cancer — a randomized controlled trial. Gynecol Oncol. 2020;159(3):672–80. DOI: 10.1016/j.ygyno.2020.09.044
45. Benmoulay-Rigollot C., Karpathiou G., Prevot-Bitot N., Heinemann M., Trombert-Paviot B., Barjat T., et al. Performance of indocyanine green compared to 99mTc-nanocolloids for sentinel lymph node detection in early vulvar cancer. Curr. Oncol. 2022;29:8084–92. DOI: 10.3390/curroncol29110638
46. Soergel P., Hertel H., Nacke A.K., Klapdor R., Derlin T., Hillemanns P. Sentinel lymphadenectomy in vulvar cancer using near-infrared fluorescence from indocyanine green compared with technetium 99m nanocolloid. Int J Gynecol Cancer. 2017;27(4):805–12. DOI: 10.1097/IGC.0000000000000996
47. Crosbie E.J., Winter-Roach B., Sengupta P., Sikand K.A., Carrington B., Murby B., et al. The accuracy of the sentinel node procedure after excision biopsy in squamous cell carcinoma of the vulva. Surg Oncol. 2010;19(4):e150–4. DOI: 10.1016/j.suronc.2010.08.003
48. Milliken S., May J., Sanderson P.A., Congiu M.A., D’Oria O., Golia D’Augè T., et al. Reducing the radicality of surgery for vulvar cancer: are smaller margins safer? Minerva Obstet Gynecol. 2021;73(2):160–5. DOI: 10.23736/S2724-606X.20.04743-7
Review
For citations:
Menshikov К.V. Sentinel Lymph Node Biopsy in Vulvar Cancer. Literature Review. Creative surgery and oncology. 2024;14(1):42-51. (In Russ.) https://doi.org/10.24060/2076-3093-2024-14-1-42-51
Views:
664
Email this article 